Duration of Dual Antiplatelet Therapy After Coronary Stenting
Year: 2016
Type: article
Source: Current Pharmaceutical Design
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dual antiplatelet therapy, coronary stenting, P2Y12 inhibitors, aspirin, clopidogrel, prasugrel, ticagrelor, bleeding risk, thrombosis risk, drug-eluting stents, bare-metal stents, acute coronary syndrome, stable coronary artery disease, diabetes mellitus, elderly patients, individualized treatment decision-making
Open Access status: closed
OpenAlex ID: W2492902010
